Feeds:
Posts
Comments

Archive for January, 2025

He was a”Master of the Universe once” – my good friend Ron Coelyn has passed

Posted in Uncategorized on January 14, 2025| Leave a Comment »

Ron was a dear friend of over 50 years.  He passed away this week from Parkinson’s disease.

Ron and I were “Masters of the Universe” in the 1970’s.  We were both put in CFO and CEO positions to stabilize, restructure and turnaound a $250 million Data Services Division.  Little did we know that this would be our first experiences as Crisis/Turnaround Managers.  Ron was a great partner; focused, smart and had high ethics and integrity.  We were a very successful team.

Over the years Ron and I worked together many times.  He was a Turnaround CEO for a number of Life Science companies, where I worked with him on capital raising and debt financing and after that he began his career as an international Executive Search CEO, where he assisted the private equity and venture capital community.

Ron and his wife Lynn moved to Texas about 15 years ago to raise and jump horses.  Although from Chicago, he became a Texan and loved Dallas.

Ron had this great smile – see below.  

Ron and I talked once a week and it always put a smile on my face when he called and said “The Gerbs”, 

His wife, Lynn, has been a saint taking care of Ron.  She put off Chemo to take care of him at home.  Lynn our condolences from our family.

Be at peace my friend, you are with “GOD” now.

With respect, with love for a friend and with admiration for the person.

Respectfully – “The Gerbs” and the Gerbsman family.

      Read Full Post »

      Gerbsman Partners – Successful Date-Certain M&A of Stemedica Cell Technologies, Inc. (a stem cell company), its Assets and Intellectual Property

      Posted in Uncategorized, tagged , , , , on January 7, 2025| Leave a Comment »

      Successful ‘Date-Certain M&A’ of Stemedica Cell Technologies Inc., its Assets and Intellectual Property

      Gerbsman Partners is pleased to announce the successful completion of maximizing the value of the Assets and Intellectual Properties at Stemedica Cell Technologies, Inc.

      Due to market conditions and trends, the Board of Directors and senior lender made the strategic decision to maximize the value of its Assets and Intellectual properties.

      Gerbsman Partners – led by Steven R. Gerbsman, Principal and Kenneth Hardesty (CEO in Residence)– provided the CEO with financial advisory leadership through its proprietary ‘Date-Certain M&A Process’, facilitated the sale of the company’s Assets and Intellectual Property and the closing of the sale with other company Advisors.

      Specifically, Gerbsman Partners provided leadership with:

      1.  Business consulting and investment banking domain expertise in developing strategic action plans.

      2.  Implementing its proprietary ‘Date-Certain M&A Process’ in order to maximize value of Stemedica Assets and Intellectual properties.

      3.  “Managing and guiding the process” among potential acquirers, lawyers, advisors, as well as all stakeholders of interest.

      About Gerbsman Partners

      Gerbsman Partners focuses on maximizing enterprise value for stakeholders and shareholders in underperforming, undercapitalized and undervalued companies and their intellectual properties. Since 2001, Gerbsman Partners has successfully maximized the values of 121 companies in a wide and diverse spectrum of industries, ranging from technology, medical device/life science, digital marketing to cyber security, to name only a few.*

      In the process, GP has successfully restructured/terminated over $810 million of real estate executory contracts and equipment lease/sub-debt obligations, and has assisted in over $2.3 billion of financings, restructurings and M&A transactions.*

      Gerbsman Partners has offices and strategic alliances in San Francisco, Orange County, Boston, New York, Washington DC, McLean, VA, Europe and Israel.

      *For further information on Gerbsman Partners expertise and industry experience, please request our company profile here

      Read Full Post »